TAKASE ZENJIRO
,
MURONOSONO ETSUO
,
MATSUMOTO YURIKO
,
TABEI TORU
,
HAYASHI SHIGERU
,
NAKAMURA HIDEYO
,
SEKI KENICHI
,
FUKUDA TOSHIKO
,
AOYAMA SHINICHI
,
KURASAWA SHIGEAKI
,
NINOMIYA KEIU
,
SHIRAFUJI HIROKO
,
HIRAOKA OSAMU
,
NAKAI TOSHIHIKO
,
SHIMIZU HARUYASU
,
SUGIMOTO OSAMU
,
KAMIYOSHI SHUICHI
,
WATANABE KATSUICHI
,
FUJIMOTO AKIRA
,
DOI SONOSUKE
,
TUJII KIYOSHIGE
,
YAMADA FUMIO
,
MATSUDA SEIJI
,
OZAWA MITSURU
,
SHIMIZU TAMOTSU
,
RISAI TERUO
,
MORIMOTO NORIHIKO
,
KOBAYASHI HACHIRO
,
KONDO ICHIRO
,
SAITA KOUJI
,
IBARAGI KENJIRO
,
KAMIGAWARA YOSHIE
,
SAWARAGI ISAMU
,
TANNO MIKIHIKO
,
YUASA MITSUO
,
HIRABAYASHI KOJI
,
OKADA ETSUKO
,
SHIRAKAWA KOICHI
,
ONIKI KANJI
,
YAMAMOTO KAZUYOSHI
,
YAMABE TOORU
,
MOTOMURA RYUTARO
,
NAKANISHI KAZUE
,
TERAMOTO CHIKAKO
,
KASHIWAKURA TAKASHI
,
ICHINOSE YOSHIO
,
NISHIMURA YUKIHIRO
,
MORI ICHIRO
,
YAMADA EIICHIRO
,
HIRA TAKAAKI
,
HARAGUCHI HIROYUKI
,
CHO NANKUN
,
FUKUNAGA KANGO
,
KUNII KATSUAKI
,
HOGAKI MASANOBU
Latamoxef (以下LMOXと略す) は塩野義製薬研究所で開発された新しい注射用Oxacephem系抗生物質で, Fig.1に示す構造式を有している。グラム陽性菌, グラム陰性菌及び嫌気性菌までの幅広い抗菌スペクトラムを持つうえ, 従来のCephalosporin系抗生物質が無効であつた<I>Proteus, Enterobacter, Serratia, Pseudomonas …
J-STAGE